View source for Risk percentage of progressionfree survival is a superb predictor of general tactical within period Three randomized governed trials evaluating your firstline chemo pertaining to extensivedisease smallcell carcinoma of the lung
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.